Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 13, 2021 - Issue
Submit an article Journal homepage
147
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy

Gianni Ghetti1 Department of Health Economics and Outcome Research, AdRes, Turin, ItalyCorrespondence[email protected]
,
Maria Claudia D’Avella2 Department of Market Access, Sanofi, Milan, Italy
&
Lorenzo Pradelli1 Department of Health Economics and Outcome Research, AdRes, Turin, ItalyORCID Iconhttps://orcid.org/0000-0002-7648-8917
ORCID Icon
Pages 121-133 | Published online: 10 Feb 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.